A Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804

NCT01313793 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Treatment A-B
DRUG: Treatment B-A

Sponsor

Pfizer